HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective deficiency of hepatic triglyceride lipase and hypertriglyceridaemia in kwashiorkor.

Abstract
1. Serum postheparin lipolytic activities (PHLA), triglyceride and free fatty acid concentrations were determined in children with kwashiorkor before and after treatment and also in normal control children. 2. Using the range (571-1650 mumol/l) of serum triglyceride of the control children as normal, five (20%) of the twenty-five children with kwashiorkor had low (less than 570 mumol/l), thirteen (52%) had normal (571-1650 mumol/l) and seven (28%) had high (more than 1650 mumol/l) serum triglyceride levels. 3. The serum PHLA did not show any definite correlation with the level of circulating triglycerides, although the lowest levels of PHLA were found in the malnourished children with highest triglyceride level. 4. While the hepatic PHLA in the malnourished children was significantly less than control value, the extrahepatic PHLA did not differ significantly. 5. After treatment, serum PHLA rose significantly and the mean levels were within normal range. 6. Our findings suggest that a defect in catabolism of very-low-density lipoprotein caused by a low hepatic PHLA may cause hypertriglyceridaemia in children with kwashiorkor.
AuthorsE O Agbedana, A O Johnson, G O Taylor
JournalThe British journal of nutrition (Br J Nutr) Vol. 42 Issue 3 Pg. 351-6 (Nov 1979) ISSN: 0007-1145 [Print] England
PMID228697 (Publication Type: Journal Article)
Chemical References
  • Fatty Acids, Nonesterified
  • Lipoproteins, VLDL
  • Triglycerides
  • Lipase
Topics
  • Body Weight
  • Child, Preschool
  • Fatty Acids, Nonesterified (blood)
  • Humans
  • Hyperlipidemias (complications)
  • Infant
  • Kwashiorkor (complications, diet therapy)
  • Lipase (deficiency)
  • Lipolysis
  • Lipoproteins, VLDL (blood)
  • Liver (metabolism)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: